The global sales of skin tears treatment is estimated to be worth USD 478.0 million in 2024 and anticipated to reach a value of USD 674.3 million by 2034. Sales are projected to grow at a CAGR of 3.5% over the forecast period between 2024 and 2034. The revenue generated by skin tears treatment in 2023 was USD 461.8 million.
Skin tear usually occur in elderly patients and fragile-skinned individuals. The causes include friction, shear forces, and blunt trauma. Skin tears usually present as a wound with skin flaps. Skin tears are categorized into three in order of severity, including partial thickness, full thickness, and flap tears.
These may well be infected and can complicate if not appropriately treated. Management ideally includes cleaning and protection, dressings to facilitate healing. Rising prevalence of chronic diseases and vascular disorders lead to more patients experiencing skin integrity issues which is expected drive the market growth over the forecast period.
Global Skin Tears Treatment Industry Assessment
| Attributes | Key Insights |
|---|---|
| Historical Size, 2023 | USD 461.8 million |
| Estimated Size, 2024 | USD 478.0 million |
| Projected Size, 2034 | USD 674.3 million |
| Value-based CAGR (2024 to 2034) | 3.5% |
One of the major driving factors in the skin tears treatment market is the aged population, which is highly vulnerable to skin injuries. Skin experiences changes in its structure with the advancement of age. With increasing age, collagen and elastin become reduced, and the skin becomes thin and fragile. Such vulnerability exposes the skin to the threat of tears, particularly for the elderly patients who have fallen or have diseases related to skin integrity.
This will further increase skin injuries, including tears, which are likely to raise demand for effective treatment modalities. Specialized care products and wound treatments for the elderly population are in very high demand-they are one of the key ways to improve outcomes and enhance quality of life.
More healthcare providers are targeting innovative product development, further driving the growth in the market through improved management of skin tears among older adults.
According to the data provided in September 2023, by World Health Organization (WHO), the global population aged 60 years and older is projected to reach approximately 2.1 billion by 2050, nearly doubling from 1 billion in 2020.
In addition, innovation such as hydrocolloid dressings, bioactive materials, and grafts to enhance the processes of wound healing and reduce various incidents that could lead to complications has also increased adoption of skin tears management products.
Inventions like these make skin tear management more effective and tailor healthcare service delivery toward individualized needs for better outcomes, thus shortening the recovery period for patients. As R&D efforts focus on developing solutions that promote faster healing and minimize scarring, the market is witnessing increased investment and interest from manufacturers, ultimately expanding the industry’s growth.
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
The global skin tears treatment market's compound annual growth rate (CAGR) for the first half of 2023 and 2024 is compared in the table below. This analysis provides important insights into the performance of the industry by highlighting significant shifts and trends in revenue generation.
The first half (H1) is the period from January to June, and the second half (H2) is July to December. In the first half (H1) of the decade from 2023 to 2033, the business is predicted to surge at a CAGR of 4.6%, followed by a slightly lower growth rate of 4.2% in the second half (H2) of the same decade.
| Particular | Value CAGR |
|---|---|
| H1 | 4.6% (2023 to 2033) |
| H2 | 4.2% (2023 to 2033) |
| H1 | 3.5% (2024 to 2034) |
| H2 | 3.1% (2024 to 2034) |
Moving into the subsequent period, from H1 2024 to H2 2034, the CAGR is projected to decrease slightly to 3.5% in the first half and remain relatively moderate at 3.1% in the second half. In the first half (H1) the industry witnessed a decrease of 110 BPS while in the second half (H2), the industry witnessed a decrease of 110 BPS.
Rising Prevalence of Chronic Diseases Drives Growth in the Skin Tears Treatment Market
The rise in chronic diseases, particularly diabetes and vascular conditions, significantly contributes to the increasing prevalence of skin tears, which acts as the major factor driving the skin tears treatment market. Skin fragility related to poor circulation, neuropathy, and delayed wound healing is common in diabetic patients.
Therefore, this population has a higher risk of injury and, consequently, of developing skin tears that could further lead to complications like infection and delayed healing. Likewise, vascular diseases impede blood circulation and decrease skin integrity, thus turning it more susceptible to all kinds of injuries.
According to the data published on May 14, 2024, by Centers for Disease Control and Prevention (CDC), approximately 537 million adults worldwide were living with diabetes in 2021, a number projected to rise to 643 million by 2030. This growing population is at an elevated risk for skin-related complications, including skin tears, due to their compromised skin condition and potential for slower healing
As these chronic conditions continue to rise, especially among aging populations, so does the demand for highly effective skin tear management solutions. Health care providers are realizing the importance of addressing skin integrity among such patients, which further means more investment in specialized wound care products and treatments. This all has contributed to the market’s growth.
Innovations in dressing materials and skin tear management is boosting the industry growth
Advancements in wound care products are a significant driver of growth in the Skin Tears Treatment market. New developments in dressing materials, like advanced hydrocolloid and foam dressings, have completely revolutionized skin tear management, as these new approaches create ideal healing environments to enhance moist tissue and provide protection against external contaminants, which has led to faster recovery and lesser pain.
In addition, the emergence of bioengineered materials and smart dressings fitted with sensors enables real-time monitoring of wound conditions to empower health professionals to make timely and informed decisions about adjusting treatment. This level of precision not only enhances effective treatment but also promotes better patient outcomes.
Increased awareness of the steps to be undertaken for proper wound management has seen manufacturing companies investing heavily in the development of innovative products for skin tear care. This innovative products trend not only meets the special needs of skin tears but also is a mirror image of the broader trend toward personalized and effective solutions for wound care; thus, huge market growth is forced.
Focus on patient-centric care is a major trend in the market
In the skin tears treatment market, personalized medicine is fulfilled by emphasizing treatments that are designed for a particular patient and condition. From the one-size-fits-all health care approach to personalized care, today clinicians are more concerned with the identification of unique risk factors, skin condition, and their healing abilities for each patient. A personalized approach will ensure that skin tear management is more efficient by choosing appropriate products and treatment protocols in each individual patient.
The dressings can be chosen regarding skin type, comorbidities, and a patient's lifestyle to bring better healing and minimize complications. Additionally, personalized education on skin care practices empowers patients to manage their skin health effectively. As technology at the front evolves to include data analytics and AI, so does the ability to personalize treatments, driving innovation in product development.
Therefore, this trend can meet the ever-increasing demands of health care, enhance patient satisfaction, promote better outcomes in patients, improve the level of engagement between a patient and a health care provider, and shape the future in the management of wounds.
Low awareness among the masses may restrict market growth
Poor patient awareness regarding the prevention and management of skin tears significantly restrains the growth of the skin tears treatment market. Many people are unaware of the dangers associated with skin tears, mainly among those in the vulnerable groups, such as elderly patients and individuals suffering from chronic diseases. This type of misconception can result in inadequate treatment and delayed treatment, thereby contributing more to complications.
Moreover, patients may be poorly informed about the availability of advanced wound care products and techniques that could further enhance the healing process or prevent re-injury. Unless properly educated, patients will tend to neglect the most important preventive measures, such as skin moisturizing and application of the right type of dressings. This can lead to poorer health and higher healthcare costs in the future, thereby limiting the market growth.
Principal Consultant
The global skin tears treatment industry recorded a CAGR of 2.9% during the historical period between 2019 and 2023. The growth of skin tears treatment industry was positive as it reached a value of USD 674.3 million in 2034 from USD 478.0 million in 2024.
Conventional treatments for skin wounds mainly involve simple dressings, such as gauze and tape or adhesive bandages, which can easily lead to complications, including infection and retarded healing. Most of them are needed to be changed frequently and cannot keep the skin moist optimally, leading to further damage. The newer technologies in wound care include advanced dressings like hydrocolloid and foam dressings.
These products create a moist healing environment, reduce pain, and allow for fewer dressing changes. Besides, other emerging innovations, such as bioengineered materials and smart dressings, can enable real-time monitoring of the wound, providing healthcare providers with critical data to make timely interventions.
Improvement in healthcare infrastructure is one of the major reasons that contributes to the growth of the skin tears treatment market in developing regions. Improved facilities, such as modern technology in both hospitals and outpatient clinics, provided access to better avenues of treatment and specialized personnel that will improve the management of wound care.
This shall offer an avenue for effective protocols in managing skin tears and ensuring timely and proper care for the patients. Moreover, investment in healthcare resources provides an impetus toward education and training of healthcare providers, which improves their competence significantly in the assessment and management of wounds.
Therefore, with strengthening and more capable health care systems, quality care leads to improved patient outcomes. Consequent to this, such a focal point on strengthening the health infrastructures addresses immediate needs of wound care while sustaining growth in the skin tears treatment market.
Tier 1 companies are the industry leaders with a market share of 46.5% of the global industry. These companies stand out for having a large product portfolio and a high production capacity.
These industry leaders also stand out for having a wide geographic reach, a strong customer base, and substantial experience in manufacturing and having enough financial resources which enables them to enhance their research and development efforts and expand into new industries. The companies within tier 1 have a good reputation and high brand value.
These companies frequently get involved in strategies such as acquisition and product launches. Prominent companies within tier 1 include 3M, ACell Inc., BSN Medical GmbH (Essity AB), Cardinal Health Inc., Coloplast A/S and ConvaTec Group Plc.
Tier 2 companies are relatively smaller as compared with tier 1 players. The tier 2 companies hold a market share of 27.1% worldwide. These firms may not have cutting-edge technology or a broad global reach, but they do ensure regulatory compliance.
The players are more competitive when it comes to pricing and target regional markets. Key Companies under this category include Covalon Technologies Ltd., Medline Industries Inc., Mölnlycke Health Care AB, Smith and Nephew Plc and Hollister Inc.
Compared to Tiers 1 and 2, Tier 3 companies offer skin tears treatment, but with smaller revenue spouts and less influence. These companies mostly operate in one or two countries and have limited customer base.
The companies such as Avery Dennison Corporation, Geistlich Pharma AG, Richardson Healthcare Ltd, Stedical Scientific, Anika Therapeutics Inc. and Others falls under tier 3 category. They specialize in specific products and cater to niche markets, adding diversity to the industry.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
The market analysis for skin tears treatment in various nations is covered in the section below. An analysis of important nations in North America, Latin America, East Asia, South Asia & Pacific, Western Europe, Eastern Europe and Middle East and Africa (MEA) has been mentioned below.
It is projected that the United States will maintain its leading position in North America through 2034, holding a value share of 89.1%. By 2034, China is expected to experience a CAGR of 3.5% in the Asia Pacific region.
| Countries | Value CAGR (2024 to 2034) |
|---|---|
| United States | 1.1% |
| Germany | 1.1% |
| France | 1.8% |
| United Kingdom | 1.3% |
| China | 3.5% |
| India | 4.0% |
| South Korea | 2.8% |
Germany’s skin tears treatment market is poised to exhibit a CAGR of 1.1% between 2024 and 2034. The Germany holds highest market share in European market.
Advancement in wound care products is one of the major growth factors for skin tears treatment in Germany. Considerable development in dressing materials through advanced types of hydrocolloid, foam, and film dressings is being witnessed in the country, specifically designed to give very conducive healing environments to the areas.
Such products keep the area moist and minimize the risk of infection, hence offering quicker recoveries and addressing patient needs much better than traditional methods.
The innovative products would most likely be adopted, given Germany's strong healthcare system with a high level of care provided, further coupled with access to advanced technologies.
With this trend, aimed at ensuring proper and more effective wound care, manufacturing companies are considering making special types of products based on demand due to growing populations that are either aging or have chronic conditions, which will increase the growth of the market within the region of Germany.
United States is anticipated to show a CAGR of 1.1% between 2024 and 2034.
The increasing prevalence of various chronic conditions, especially diabetes and vascular diseases, is one of the primary growth factors that contribute to the skin tears treatment market in the United States.
With these types of diseases becoming more widespread, the risk of experiencing skin tears will also increase, mainly for the elderly and those people with weaker skin integrity. This, therefore, creates a larger patient population in demand for specialized wound care treatments that effectively manage such skin injuries and facilitate the healing process.
Thus, health care providers develop a huge interest in innovation in developing tailored treatment plans and products to meet the special needs of such patients. In addition, preventive care and early intervention continue to drive the market in this country, given that healthcare systems work for the minimization of complications and improvement in the quality of life among populations at risk for skin tears.
China is anticipated to show a CAGR of 3.5% between 2024 and 2034.
Increasing awareness and education regarding the prevention and management of skin tears are some of the important growth factors in the China for the skin tears treatment market. With increased knowledge among healthcare professionals about the risks of skin tears, especially among vulnerable populations such as the elderly and people with chronic conditions, they can take proper measures to prevent such incidences and adopt effective treatment options.
Patient education is also on the rise in China, and individuals are being made more aware of the need for skin care and early treatment of wounds. Awareness on both fronts promotes better adherence to wound care management and encourages the use of more advanced treatment products.
The market is therefore growing due to the combined efforts of health care providers and patients in the pursuit of better outcomes and a reduction in the incidence of skin tears throughout the country.
The section contains information about the leading segments in the industry. Based on product, the moisture-retentive dressing segment is expected to account for 53.8% of the global share in 2024.
| Product | Moisture-retentive Dressing |
|---|---|
| Value Share (2024) | 53.8% |
The moisture-retentive dressing segment is projected to be a dominating segment in terms of revenue, accounting for almost 53.8% of the market share in 2024.
The moisture-retentive dressing segment is expected to dominate the skin tears treatment market because it possesses extremely good wound-healing properties. These kinds of dressings maintain a moist atmosphere that generally accelerates the healing process and reduces pain and scarring. They are also easy to apply and remove with minimal trauma to fragile skin.
Adoption rates are growing considering increasing awareness among health professionals and patients about their effectiveness in treatment. With the development of advanced materials and technologies, the performances of these dressings continue improving, hence making them a preference choice in both clinical and home care settings, driving their market share.
Versatility of moisture-retentive dressings when it comes to various stages in wound healing helps widen the spectrum of their dominance in the global skin tears treatment market.
Such dressings fall into a long list, including hydrocolloid ones, hydrogel, or foam, depending on the specific conditions associated and levels of possible exudate. Proper application of this feature enables customizing treatment for each patient, thus increasing the possibilities of a better outcome.
| Type of Skin Tear | Type 1 Skin Tear |
|---|---|
| Value Share (2024) | 37.6% |
The type 1 skin tear segment will dominate the industry in terms of revenue, accounting for almost 37.6% of the market share in 2024.
The type 1 skin tear segment is expected to dominate the market because of its particular characteristics and management needs. The most common lacerations are type 1 tears, which are linear with minimal skin loss, and usually occur in frail elderly patients. The management is relatively easier, with good healing, hence a major concern for healthcare providers.
There is increased awareness and improved practices for wound care; thus, there is an increased stride of healthcare professionals towards the proper management of type 1 tears, hence an increased demand for specific treatments. This focus on efficient solutions in care further secures the leading position of the segment in the market.
The increasing age-related geriatric population increases the incidence of type 1 skin tears mainly due to the factors of skin fragility caused by age. This factor has also contributed significantly to the segmental market dominance. Preventive care-emphasized along with treatment solutions such as specialized barrier products and protective measures-has attracted sustained global demand and growth in the segment.
The skin tears treatment industry faces a high competition, as there are large number of skin tears treatment manufacturers. These manufacturers are focused on constantly innovating and improving their product portfolio.
Prominent producers of skin tears treatment are concentrating on growing internationally in order to increase their revenue and increase the size of their sales footprint in developing nations through the acquisition of regional small players. Manufacturers utilize various key strategies such as partnerships, agreements, product launches, research sponsorship, and strategic collaborations to boost product sales and establish their market presence.
Recent Industry Developments in Skin Tears Treatment Market
In terms of product, the industry is divided into moisture-retentive dressing (mesh dressing, foam dressing, hydrogel dressing, silicone dressing, alginate dressing, acrylic dressing, hydrocolloid dressing, and hydrofiber dressing), dressing adhesives & fixators (adhesive fixation products and non-adhesive fixation products), barrier films, hyaluronic acid, wound devices, contact layer dressing, 2-octyl cyanoacrylate topical bandages, gels & cream and skin closure strips.
In terms of type of skin tear, the industry is segregated into type 1 skin tear, type 2 skin tear, and type 3 skin tear
In terms of distribution channel, the industry is divided into hospital pharmacies, retail pharmacies, specialty pharmacies and mail order pharmacies
Key countries of North America, Latin America, East Asia, South Asia & Pacific, Western Europe, Eastern Europe and Middle East and Africa (MEA) have been covered in the report.
The global skin tears treatment industry is projected to witness CAGR of 3.5% between 2024 and 2034.
The global skin tears treatment industry stood at USD 461.8 million in 2023.
The global skin tears treatment industry is anticipated to reach USD 674.3 million by 2034 end.
China is expected to show a CAGR of 3.5% in the assessment period.
The key players operating in the global skin tears treatment industry 3M, ACell Inc., BSN Medical GmbH (Essity AB), Cardinal Health Inc., Coloplast A/S, ConvaTec Group Plc, Covalon Technologies Ltd., Medline Industries Inc., Mölnlycke Health Care AB, Smith and Nephew Plc, Hollister Inc, Avery Dennison Corporation, Geistlich Pharma AG, Richardson Healthcare Ltd, Stedical Scientific and Anika Therapeutics Inc.
Explore Healthcare Insights
View Reports
Skin Tears Treatment Market
